BioCorRx Inc. (BICX)
USD 0.35
(-29.72%)
USD 0.35
(-29.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.68 Million USD | -20.03% |
| 2022 | -3.14 Million USD | 31.96% |
| 2021 | -4.47 Million USD | -53.23% |
| 2020 | -2.82 Million USD | 34.63% |
| 2019 | -4.32 Million USD | 0.94% |
| 2018 | -4.61 Million USD | 89.3% |
| 2017 | -18.52 Million USD | -489.74% |
| 2016 | -2.15 Million USD | -40.74% |
| 2015 | -1.35 Million USD | -47.02% |
| 2014 | -2.91 Million USD | 1.35% |
| 2013 | -2.36 Million USD | -445.2% |
| 2012 | -621.97 Thousand USD | -81.74% |
| 2011 | -341.33 Thousand USD | -1316.77% |
| 2010 | -131.76 Thousand USD | -83.04% |
| 2009 | -13.19 Thousand USD | -162.84% |
| 2008 | -6021.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.34 Million USD | 17.51% |
| 2024 Q1 | -935.36 Thousand USD | -42.17% |
| 2023 FY | - USD | -20.03% |
| 2023 Q4 | -735.82 Thousand USD | -18.21% |
| 2023 Q3 | -622.47 Thousand USD | 5.86% |
| 2023 Q2 | -661.22 Thousand USD | 9.45% |
| 2023 Q1 | -730.21 Thousand USD | 21.65% |
| 2022 Q1 | -771.35 Thousand USD | 22.29% |
| 2022 FY | - USD | 31.96% |
| 2022 Q4 | -932.04 Thousand USD | -101.23% |
| 2022 Q3 | -463.17 Thousand USD | 42.84% |
| 2022 Q2 | -810.25 Thousand USD | -5.04% |
| 2021 Q2 | -889.9 Thousand USD | 37.16% |
| 2021 FY | - USD | -53.23% |
| 2021 Q3 | -1.03 Million USD | -16.36% |
| 2021 Q4 | -992.55 Thousand USD | 4.14% |
| 2021 Q1 | -1.41 Million USD | -94.5% |
| 2020 Q4 | -728.05 Thousand USD | -18.6% |
| 2020 Q3 | -613.9 Thousand USD | -6.92% |
| 2020 Q2 | -574.19 Thousand USD | 36.94% |
| 2020 Q1 | -910.52 Thousand USD | 10.46% |
| 2020 FY | - USD | 34.63% |
| 2019 Q4 | -1.01 Million USD | -65.85% |
| 2019 Q2 | -1.45 Million USD | 1.67% |
| 2019 Q1 | -1.47 Million USD | 21.09% |
| 2019 Q3 | -613.15 Thousand USD | 57.82% |
| 2019 FY | - USD | 0.94% |
| 2018 Q4 | -1.87 Million USD | -34.14% |
| 2018 FY | - USD | 89.3% |
| 2018 Q3 | -1.39 Million USD | -88.69% |
| 2018 Q2 | -740.1 Thousand USD | -38.21% |
| 2018 Q1 | -535.5 Thousand USD | 73.59% |
| 2017 Q2 | 10.85 Million USD | 122.57% |
| 2017 Q1 | -48.08 Million USD | -2157.93% |
| 2017 Q4 | -2.02 Million USD | -30.18% |
| 2017 FY | - USD | -489.74% |
| 2017 Q3 | -1.55 Million USD | -114.35% |
| 2016 Q4 | -2.12 Million USD | 24.01% |
| 2016 Q2 | -1.29 Million USD | -257.27% |
| 2016 FY | - USD | -40.74% |
| 2016 Q1 | -362.78 Thousand USD | -2249.15% |
| 2016 Q3 | -2.8 Million USD | -116.24% |
| 2015 Q1 | -269.45 Thousand USD | 86.48% |
| 2015 Q3 | -503.82 Thousand USD | 86.29% |
| 2015 Q2 | -3.67 Million USD | -1263.55% |
| 2015 FY | - USD | -47.02% |
| 2015 Q4 | -15.44 Thousand USD | 96.93% |
| 2014 Q3 | -218.28 Thousand USD | -143.45% |
| 2014 FY | - USD | 1.35% |
| 2014 Q1 | -969 Thousand USD | 70.52% |
| 2014 Q2 | 502.37 Thousand USD | 151.84% |
| 2014 Q4 | -1.99 Million USD | -812.82% |
| 2013 Q3 | -66.19 Thousand USD | 8.95% |
| 2013 Q2 | -72.7 Thousand USD | -307.44% |
| 2013 Q1 | 35.04 Thousand USD | 131.33% |
| 2013 FY | - USD | -445.2% |
| 2013 Q4 | -3.28 Million USD | -4865.71% |
| 2012 Q3 | -120.27 Thousand USD | 68.14% |
| 2012 Q2 | -377.48 Thousand USD | -2958.27% |
| 2012 FY | - USD | -81.74% |
| 2012 Q1 | -12.34 Thousand USD | 97.31% |
| 2012 Q4 | -111.87 Thousand USD | 6.99% |
| 2011 Q3 | -1270.00 USD | 76.07% |
| 2011 Q1 | -9448.00 USD | -58.44% |
| 2011 FY | - USD | -1316.77% |
| 2011 Q4 | -458.38 Thousand USD | -35992.99% |
| 2011 Q2 | -5308.00 USD | 43.82% |
| 2010 Q4 | -5963.00 USD | -34.18% |
| 2010 FY | - USD | -83.04% |
| 2010 Q1 | -6188.00 USD | -17.17% |
| 2010 Q2 | -6752.00 USD | -9.11% |
| 2010 Q3 | -4444.00 USD | 34.18% |
| 2009 Q3 | -454.00 USD | 88.24% |
| 2009 Q1 | -4510.00 USD | -80.33% |
| 2009 FY | - USD | -162.84% |
| 2009 Q4 | -5281.00 USD | -1063.22% |
| 2009 Q2 | -3860.00 USD | 14.41% |
| 2008 Q3 | -2520.00 USD | -380.0% |
| 2008 Q4 | -2501.00 USD | 0.75% |
| 2008 Q1 | -4510.00 USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | -525.00 USD | 88.36% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 75.564% |
| Arem Pacific Corporation | 36.71 Thousand USD | 7410.151% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | -2277.024% |
| Bionik Laboratories Corp. | -4.77 Million USD | 43.801% |
| Banyan Corp. | 583.94 Thousand USD | 559.621% |
| Clearday, Inc. | -7.53 Million USD | 64.387% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | 20949.235% |
| Quantum Medical Transport, Inc. | - USD | Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | -146.621% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | -21.456% |
| Selectis Health, Inc. | -7.29 Million USD | 63.205% |
| Ethema Health Corporation | 2.07 Million USD | 229.522% |
| HealthLynked Corp. | -2.75 Million USD | 2.414% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | -1.113% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | 9404.313% |
| Comjoyful International Company | 167.89 Thousand USD | 1698.572% |
| Medical Facilities Corporation | 77.94 Million USD | 103.443% |
| MedSmart Group Inc. | 47.8 Thousand USD | 5713.843% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | -330.578% |
| Nova Leap Health Corp. | 994.46 Thousand USD | 369.886% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | -1230.453% |
| PAO Group, Inc. | 292.96 Thousand USD | 1016.13% |
| Primemd Inc. | 3.42 Million USD | 178.318% |
| Raffles Medical Group Ltd | 100.7 Million USD | 102.665% |
| Ryman Healthcare Limited | -54.51 Million USD | 95.077% |
| Stem Cell Authority, Ltd. | -4233.00 USD | -63304.725% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 7.267% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | -383.148% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | -5377.392% |
| Veltex Corporation | -938.45 Thousand USD | -185.993% |
| World Financial Holding Group | -28.43 Thousand USD | -9340.457% |
| Xcelerate Inc. | -2.53 Million USD | -5.735% |